Matthew White
Finanzdirektor/CFO bei APIAM ANIMAL HEALTH LIMITED
Vermögen: 37 926 $ am 30.04.2024
Profil
Matthew White is currently the Chief Financial Officer at Apiam Animal Health Ltd.
since 2015.
Prior to this, he worked as a Finance Director at Merck Sharp & Dohme (Australia) Pty Ltd.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
APIAM ANIMAL HEALTH LTD.
0,08% | 30.06.2023 | 146 017 ( 0,08% ) | 37 926 $ | 30.04.2024 |
Aktive Positionen von Matthew White
| Unternehmen | Position | Beginn |
|---|---|---|
| APIAM ANIMAL HEALTH LIMITED | Finanzdirektor/CFO | 01.08.2015 |
Ehemalige bekannte Positionen von Matthew White
| Unternehmen | Position | Ende |
|---|---|---|
Merck Sharp & Dohme (Australia) Pty Ltd.
 Merck Sharp & Dohme (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Sharp & Dohme (Australia) Pty Ltd. is an Australian research-intensive biopharmaceutical company committed to saving and improving lives. The private company is based in North Ryde, Australia and is dedicated to following the science to tackle some of the world's greatest health threats. MSD Australia has a long legacy of research in infectious disease and has been mobilizing its scientific expertise and experience to develop an effective response to the COVID-19 pandemic since it was first recognized. | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| APIAM ANIMAL HEALTH LIMITED | Distribution Services |
| Private Unternehmen | 1 |
|---|---|
Merck Sharp & Dohme (Australia) Pty Ltd.
Merck Sharp & Dohme (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Sharp & Dohme (Australia) Pty Ltd. is an Australian research-intensive biopharmaceutical company committed to saving and improving lives. The private company is based in North Ryde, Australia and is dedicated to following the science to tackle some of the world's greatest health threats. MSD Australia has a long legacy of research in infectious disease and has been mobilizing its scientific expertise and experience to develop an effective response to the COVID-19 pandemic since it was first recognized. | Health Technology |
